These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 26365224

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antibiotic treatment of anaerobic infections.
    Gorbach SL.
    Clin Infect Dis; 1994 May; 18 Suppl 4():S305-10. PubMed ID: 8086580
    [Abstract] [Full Text] [Related]

  • 24. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
    Ginunas VJ, Canawati HN, Sapico FL.
    Clin Ther; 1984 May; 6(4):457-60. PubMed ID: 6467279
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP, Pottumarthy S, Morris AJ.
    N Z Med J; 1999 Nov 12; 112(1099):424-6. PubMed ID: 10678225
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012.
    Lee Y, Park YJ, Kim MN, Uh Y, Kim MS, Lee K.
    Ann Lab Med; 2015 Sep 12; 35(5):479-86. PubMed ID: 26206683
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A, Rawte P, Toye B, Jamieson FB, Farrell DJ, Patel SN.
    Anaerobe; 2014 Aug 12; 28():120-5. PubMed ID: 24923267
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anaerobic pulmonary infections in children.
    Brook I.
    Pediatr Emerg Care; 2004 Sep 12; 20(9):636-40. PubMed ID: 15599270
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The consequences of suppression of anaerobic bacteria.
    Fry DE, Schermer CR.
    Surg Infect (Larchmt); 2000 Sep 12; 1(1):49-56. PubMed ID: 12594909
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial resistance and the management of anaerobic infections.
    Boyanova L, Kolarov R, Mitov I.
    Expert Rev Anti Infect Ther; 2007 Aug 12; 5(4):685-701. PubMed ID: 17678430
    [Abstract] [Full Text] [Related]

  • 38. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP.
    J Infect; 2006 Nov 12; 53(5):293-300. PubMed ID: 16876253
    [Abstract] [Full Text] [Related]

  • 39. Antibiotic treatment of anaerobic infections.
    Panichi G.
    Scand J Infect Dis Suppl; 1989 Nov 12; 62():47-51. PubMed ID: 2685992
    [Abstract] [Full Text] [Related]

  • 40. Anaerobic bacteria in upper respiratory tract and head and neck infections: microbiology and treatment.
    Brook I.
    Anaerobe; 2012 Apr 12; 18(2):214-20. PubMed ID: 22197951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.